AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $603,190 | -24.5% | 77,332 | -3.3% | 0.00% | 0.0% |
Q2 2023 | $799,200 | -10.0% | 80,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $888,000 | +153.9% | 80,000 | -2.8% | 0.00% | – |
Q4 2022 | $349,790 | -44.7% | 82,303 | -1.0% | 0.00% | -100.0% |
Q3 2022 | $632,000 | -72.8% | 83,144 | -64.3% | 0.00% | -66.7% |
Q2 2022 | $2,320,000 | -61.9% | 233,207 | -51.7% | 0.00% | -57.1% |
Q1 2022 | $6,084,000 | -46.2% | 483,263 | +0.5% | 0.01% | -30.0% |
Q4 2021 | $11,319,000 | +609.2% | 480,665 | +571.5% | 0.01% | +400.0% |
Q3 2021 | $1,596,000 | +762.7% | 71,585 | +409.9% | 0.00% | – |
Q2 2021 | $185,000 | +14.9% | 14,039 | +19.3% | 0.00% | – |
Q4 2020 | $161,000 | -8.0% | 11,765 | -1.4% | 0.00% | – |
Q3 2020 | $175,000 | -29.4% | 11,931 | -21.8% | 0.00% | – |
Q2 2020 | $248,000 | – | 15,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |